Figure 3.
Cost-effectiveness of childhood cancer treatments*. ALL, acute lymphoblastic leukaemia; BL, Burkitt lymphoma; DALY, disability-adjusted life year; GDP, gross domestic product. *Only includes studies with extracted or calculated cost per DALY averted that were ranked as ‘Comprehensive’ or ‘Medium’ for number of inputs included in cost analysis.